Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor used in adults with type 2 diabetes, chronic kidney disease ...
Despite his doctors’ recommendations, President Trump takes a high dose. By Nina Agrawal President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical ...
Nonetheless, the authors concluded, “Liver biopsy is considered the gold standard for diagnosing MASH and MASLD. While ...
The assured buyback offer applies to all three electric vehicles currently sold by MG in India: the MG Comet EV, MG Windsor EV, and MG ZS EV. In addition, MG has confirmed that commercial users of the ...
Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...
MG continues to make leaps and bounds with the quality and presentation of its products, but the MG S5 shows where that progress might be slowing. The MG S5 EV sits on a slightly larger footprint than ...
Under the industry-first initiative, MG EV owners can opt for a guaranteed resale value after three, four or five years, depending on the plan chosen. The programme builds on the company’s earlier ...
The MG QS is the brand's first stab at a seven-seat SUV, providing more space and seating options for families in need of a more versatile vehicle. How does it fare compared to its rivals, and is it ...
President Donald Trump pushed back on critics who have questioned the state of his health, telling The Wall Street Journal in an interview published Thursday that he denies falling asleep in meetings ...
At some point, one of the Chinese brands has got to go crazy and do something fun. And MG, in some ways the least Chinese of the lot, could be in a strong position to capitalise on the dearth of ...
President Donald Trump said he takes a higher dose of daily aspirin than his doctors recommend and he has been doing so for 25 years. The comments came in a wide-ranging interview with The Wall Street ...